注射用泮托拉唑钠工艺研究论文

《注射用泮托拉唑钠工艺研究论文》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、注射用泮托拉唑钠工艺研究毕业论文目录摘要··········································································1关键词······································································1.注射用泮托拉唑钠概述························································31.1品名··················

2、·····················································31.2结构式·····································································31.3理化性质··································································``31.4药理毒理···············································

3、····················3251.5药代动力学·································································41.6临床应用···································································42.处方依据····································································42.1依据········

4、······························································42.2主药和辅料的作用···························································43.生产工艺····································································53.1工艺流程图···········································

5、······················53.2主要生产操作·······························································63.3中间体过程质量控制25·························································73.4岗位质量监控要点···························································84.原料及成品质量标准··········

6、················································94.1原料质量标准·······························································94.2成品质量标准······························································105.主要生产设备·························································

7、······106.安全和劳动保护·····························································116.1安全······································································116.2劳动保护··································································11257.原辅料、包装材料消耗定额············

8、········································118.物料平衡计算公式··························································128.1理论收量的计算··························································